Lycia Therapeutics logo

Senior Manager, Supply Chain and Clinical Supply

Lycia Therapeutics

South San Francisco, CAOnsitePosted 1 day ago$165,000 - $180,000/year
Full TimeSenior LevelOperations & Supply ChainBiotechnology
Original posting ↗

Summary

Lycia is seeking an experienced Senior Manager, Supply Chain and Clinical Supply to lead supply chain operations and clinical supply management for its development programs. The role oversees material planning, procurement, inventory management, GMP logistics and clinical trial supply to ensure timely and compliant delivery of investigational products.

Job description

Key Responsibilities

Supply chain management

  • Develop and execute supply chain strategies supporting CMC development and clinical programs.
  • Manage procurement, material planning, inventory and logistics for drug substance (DS) and drug product (DP) manufacturing.
  • Coordinate with CDMOs, CROs and other external vendors to ensure material availability and on-time delivery.
  • Oversee GMP material storage, temperature-controlled transportation and import and export activities.
  • Manage supplier performance, supply chain risks, budgets and operational timelines.

Clinical supply management

  • Develop clinical supply plans based on clinical protocols, enrollment forecasts and study timelines.
  • Coordinate clinical packaging, labeling, distribution and inventory management of investigational medicinal products (IMPs).
  • Manage clinical supply vendors, depots and distribution to clinical sites globally.
  • Monitor clinical inventory, expiration dates, resupply requirements and drug accountability.
  • Ensure compliance with applicable GMP, GCP and regulatory requirements.

Cross-functional collaboration

  • Partner with CMC, Clinical Operations, Quality Assurance, Regulatory Affairs and Finance to align supply plans with program milestones.
  • Support IND and CTA submissions and clinical trial initiation through supply readiness.
  • Identify supply risks and implement mitigation and contingency plans.

Qualifications

  • Bachelor's degree in supply chain management, pharmaceutical sciences, engineering or a related field. An advanced degree is preferred.
  • 7 or more years of experience in pharmaceutical or biotechnology supply chain operations, including clinical supply management.
  • Experience supporting biologics development and Phase 1-3 clinical trials.
  • Strong understanding of GMP requirements, clinical supply logistics and global distribution.
  • Experience managing CDMOs, clinical packaging vendors and third-party logistics providers.
  • Excellent project management, communication and cross-functional coordination skills.
  • Experience in a startup or emerging biotechnology company is preferred.

Preferred qualifications

  • Experience with global clinical trials, including U.S., Canadian and EU supply requirements.
  • Familiarity with IRT and RTSM systems, clinical labeling and cold-chain logistics.
  • Experience supporting multiple clinical programs simultaneously in a fast-paced environment.

Requirements

  • Bachelor's degree in supply chain management, pharmaceutical sciences, engineering or a related field
  • 7 or more years of experience in pharmaceutical or biotechnology supply chain operations, including clinical supply management
  • Experience supporting biologics development and Phase 1-3 clinical trials
  • Strong understanding of GMP requirements, clinical supply logistics and global distribution
  • Experience managing CDMOs, clinical packaging vendors and third-party logistics providers
  • Excellent project management, communication and cross-functional coordination skills

Benefits

  • Annual performance bonus
  • Equity
  • Benefits program

Company overview

Lycia Therapeutics is a biotechnology company pioneering a novel approach to treating previously undruggable diseases through extracellular protein degradation. Founded in 2020 and headquartered in South San Francisco, California, the company is developing innovative LYTAC (Lysosome-Targeting Chimera) therapeutics designed to bind and eliminate disease-causing extracellular proteins by directing them into cells for degradation via the lysosome. The company's platform technology specifically targets proteins outside the cell, addressing a significant gap in current therapeutic approaches. Lycia initially focuses on autoimmune and inflammatory diseases, with lead programs targeting conditions like allergic asthma, chronic urticaria, and Graves' disease. The company has raised substantial funding, including a $106.6 million Series C round in 2024, demonstrating strong investor confidence in their technology platform. Lycia's modular therapeutics can be customized for various pathogenic proteins, offering new hope for patients with limited treatment options.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.